Stock Events

Alnylam Pharmaceuticals (ALNY) Q1 2024 Earnings

15FebConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-2.21
-0.89
0.42
1.74

Details

Expected EPS
-1.26
Actual EPS
-0.77
Surprise EPS
0.49
Surprise Percent
+38.89%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.77 per share for Q1 2024.

0 Comments

Share your thoughts